Animal Models & Clinical Trials

The development of human vaccines continues to rely on the use of animals for research. Regulatory authorities require novel vaccine candidates to undergo preclinical assessment in animal models before being permitted to enter the clinical phase in human subjects. Substantial progress has been made in recent years in reducing and replacing the number of animals used for preclinical vaccine research through the use of bioinformatics and computational biology to design new vaccine candidates. However, the ultimate goal of a new vaccine is to instruct the immune system to elicit an effective immune response against the pathogen of interest, and no alternatives to live animal use currently exist for evaluation of this response.

 


    Related Conference of Animal Models & Clinical Trials

    March 18-19, 2021

    3rd World Conference on Vaccine and Immunology

    Dubai, UAE
    March 24-24, 2021

    3rd International Conference on Dermatology and Allergic Diseases

    Singapore City, Singapore
    April 15-16, 2021

    Tumor & Cancer Immunology and Pediatric-Oncology

    Toronto, Canada
    April 26-27, 2021

    36th International Conference on Immunology

    Rome, Italy
    May 03-04, 2021

    International Online Conference on Immunology

    New York, USA
    May 06-07, 2021

    9th World Summit on immunology & immunotherapy

    Prague, Czech Republic
    June 23-24, 2021

    34th World Congress on Vaccines and Immunization

    Osaka, Australia
    October 12-13, 2021

    International Conference on Vaccine and Vaccine research

    Manila, Philippines
    October 14-15, 2021

    13th Annual Conference on Cinical Immunology

    Cape Town, Australia
    October 14-15, 2021

    11th International Conference on Bacteriology and Infectious Diseases

    Cape Town, South Africa

    Animal Models & Clinical Trials Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in